• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ascidian Therapeutics

Flat lay composition with whole cut apples and seeds on green background
Biotech

Apple Tree Partners files for Chapter 11 bankruptcy

Two affiliates of Apple Tree Partners have filed for bankruptcy, a move designed to continue funding the venture capital firm's portfolio companies.
Gabrielle Masson Dec 10, 2025 4:54pm
parasailing over clouds in Salzburg Austria

Incyte, FDA, Sun Pharma and more—Chutes & Ladders

Jun 27, 2025 8:30am
picture of a paraglider

CRISPR-focused Caribou christens new CMO—Chutes & Ladders

Aug 16, 2024 8:30am
Fierce 15 Hero

Introducing Fierce Biotech's 2024 Fierce 15

Aug 5, 2024 6:00am
Three blocks displaying from left to right a person a handshake and another person

Roche pays Ascidian $42M to develop RNA exon editing drugs

Jun 18, 2024 7:00am
CL paragliding mountain

BIO CEO out the door—Chutes & Ladders

Oct 14, 2022 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings